Home › Lipoid Nephrosis › Georgia
Lipoid Nephrosis clinical trials in Georgia
4 studies for Lipoid Nephrosis are looking for participants at sites in Georgia.
Cities in Georgia
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Emory Children's Center- Site Number : 8400020, Atlanta
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Fides Clinical Research, Atlanta
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135NEPTUNE Match Study
- Emory University Hospital - Children's Hospital of Atlanta, Atlanta
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Emory University and Children's Healthcare of Atlanta, Atlanta
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.